Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 30, 2011 18:00 ET | Source: MediciNova, Inc.

MediciNova, Inc. Appoints Kousuke Nakata to Its Board of Directors

SAN DIEGO, Calif., Nov. 30, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities...
November 15, 2011 06:00 ET | Source: MediciNova, Inc.

MediciNova Reports Third Quarter 2011 Results

SAN DIEGO, Nov. 15, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...
November 09, 2011 17:00 ET | Source: MediciNova, Inc.

MediciNova to Present at the Lazard Capital Markets Healthcare Conference

SAN DIEGO, Nov. 9, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...
October 27, 2011 19:00 ET | Source: MediciNova, Inc.

MediciNova Announces Repeat Dose Clinical Trial With MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients

SAN DIEGO, Oct. 27, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange...
October 13, 2011 19:00 ET | Source: MediciNova, Inc.

MediciNova to Receive $2.5 Million Payment From Kissei Pharmaceutical Co. Ltd. to Expand Clinical Development of the MN-221 Program

SAN DIEGO, Oct. 13, 2011 (GLOBE NEWSWIRE) -- MediciNova Inc., a biopharmaceutical company publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities...
October 12, 2011 19:00 ET | Source: MediciNova, Inc.

MediciNova Closes $7.5 Million Private Stock Sale to Kissei Pharmaceutical Co., Ltd.

SAN DIEGO, Oct. 12, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange...
September 26, 2011 23:00 ET | Source: MediciNova, Inc.

MediciNova, Inc. Announces Private Sale of Stock to Kissei Pharmaceutical Co., Ltd.

SAN DIEGO, Sept. 26, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange...
September 26, 2011 02:30 ET | Source: MediciNova, Inc.

MediciNova, Inc. Appoints Mr. Tatsuo Izumi to Its Board of Directors

SAN DIEGO, Sept. 26, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange...
September 02, 2011 06:00 ET | Source: MediciNova, Inc.

MediciNova Announces Management Appointments

SAN DIEGO, Sept. 2, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...
August 16, 2011 06:00 ET | Source: MediciNova, Inc.

MediciNova Reports Second Quarter 2011 Results

SAN DIEGO, Aug. 16, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...